83North

Ibex Medical Analytics Ltd, based in Tel Aviv, Israel, specializes in developing AI-based diagnostic systems for cancer pathology. The company's flagship product, the Ibex Second Read system, works alongside human pathologists to analyze cases, identifying discrepancies in diagnoses. This innovative technology harnesses artificial intelligence, data science, and machine learning to analyze digitized glass slides and electronic medical records, revealing critical patterns that enhance clinical decision-making. By streamlining pathology workflows, Ibex aims to provide rapid, objective, and accurate diagnoses, ultimately improving patient outcomes and quality of life. The company comprises a multidisciplinary team of entrepreneurs, data scientists, software engineers, and medical experts dedicated to advancing cancer care through AI applications in diagnostics.

Foretellix Ltd. is a company specializing in the development of a verification framework for Intelligent Autonomous Systems, particularly focusing on Autonomous Vehicles. Established in 2010 and headquartered in Tel Aviv, Israel, Foretellix provides innovative solutions that automate the verification of safety-critical automotive systems. The company has created a platform that enables measurable safety verification, utilizing a coverage-driven methodology that has been successfully applied in the semiconductor industry. This platform facilitates the analysis of safety-related metrics to ensure comprehensive coverage of various driving scenarios, allowing clients to confirm that their vehicles perform safely in critical situations. By addressing the challenges of verifying increasingly complex automated driving systems, Foretellix aims to reduce risks, costs, and time to market for autonomous vehicle deployment.

Opsys Technology Co., Ltd. specializes in designing and developing optical communication products, focusing on solutions that utilize advanced fiber optics technologies. The company's product offerings include LIDAR systems, RF over fiber links for various applications such as remote antenna and distributed antenna systems, as well as mixed signal solutions for aircraft and maritime environments. Opsys Tech is also active in sectors requiring temperature and strain sensors, as well as data center switching technologies. With a strong emphasis on autonomous vehicle control and intelligent sensors, the company is committed to innovating new applications within the optical market. Founded as a spinoff from a leading optical communication firm, Opsys Tech is based in Holon, Israel, and continues to expand its portfolio to meet the demands of modern technological advancements.

Ibex Medical Analytics Ltd, based in Tel Aviv, Israel, specializes in developing AI-based diagnostic systems for cancer pathology. The company's flagship product, the Ibex Second Read system, works alongside human pathologists to analyze cases, identifying discrepancies in diagnoses. This innovative technology harnesses artificial intelligence, data science, and machine learning to analyze digitized glass slides and electronic medical records, revealing critical patterns that enhance clinical decision-making. By streamlining pathology workflows, Ibex aims to provide rapid, objective, and accurate diagnoses, ultimately improving patient outcomes and quality of life. The company comprises a multidisciplinary team of entrepreneurs, data scientists, software engineers, and medical experts dedicated to advancing cancer care through AI applications in diagnostics.

Five Sigma LTD. is a software company based in Tel Aviv-Yafo, Israel, that specializes in automating the claims management process for the insurance industry through its cloud-based platform. Founded in 2017, Five Sigma offers a data-driven Claims Management Solution that incorporates artificial intelligence and machine learning capabilities. This platform streamlines claims processing by implementing automated workflows and utilizing data modeling to provide insightful recommendations, enhancing decision-making for insurance adjusters and minimizing errors. The solution is utilized by various entities within the insurance sector, including leading insurance carriers, Insurtech firms, third-party administrators, and self-insured organizations, to modernize their claims operations, reduce claims leakage, ensure compliance, and enhance overall customer experience.

Foretellix Ltd. is a company specializing in the development of a verification framework for Intelligent Autonomous Systems, particularly focusing on Autonomous Vehicles. Established in 2010 and headquartered in Tel Aviv, Israel, Foretellix provides innovative solutions that automate the verification of safety-critical automotive systems. The company has created a platform that enables measurable safety verification, utilizing a coverage-driven methodology that has been successfully applied in the semiconductor industry. This platform facilitates the analysis of safety-related metrics to ensure comprehensive coverage of various driving scenarios, allowing clients to confirm that their vehicles perform safely in critical situations. By addressing the challenges of verifying increasingly complex automated driving systems, Foretellix aims to reduce risks, costs, and time to market for autonomous vehicle deployment.

Ibex Medical Analytics Ltd, based in Tel Aviv, Israel, specializes in developing AI-based diagnostic systems for cancer pathology. The company's flagship product, the Ibex Second Read system, works alongside human pathologists to analyze cases, identifying discrepancies in diagnoses. This innovative technology harnesses artificial intelligence, data science, and machine learning to analyze digitized glass slides and electronic medical records, revealing critical patterns that enhance clinical decision-making. By streamlining pathology workflows, Ibex aims to provide rapid, objective, and accurate diagnoses, ultimately improving patient outcomes and quality of life. The company comprises a multidisciplinary team of entrepreneurs, data scientists, software engineers, and medical experts dedicated to advancing cancer care through AI applications in diagnostics.

Ibex Medical Analytics Ltd, based in Tel Aviv, Israel, specializes in developing AI-based diagnostic systems for cancer pathology. The company's flagship product, the Ibex Second Read system, works alongside human pathologists to analyze cases, identifying discrepancies in diagnoses. This innovative technology harnesses artificial intelligence, data science, and machine learning to analyze digitized glass slides and electronic medical records, revealing critical patterns that enhance clinical decision-making. By streamlining pathology workflows, Ibex aims to provide rapid, objective, and accurate diagnoses, ultimately improving patient outcomes and quality of life. The company comprises a multidisciplinary team of entrepreneurs, data scientists, software engineers, and medical experts dedicated to advancing cancer care through AI applications in diagnostics.

Foretellix Ltd. is a company specializing in the development of a verification framework for Intelligent Autonomous Systems, particularly focusing on Autonomous Vehicles. Established in 2010 and headquartered in Tel Aviv, Israel, Foretellix provides innovative solutions that automate the verification of safety-critical automotive systems. The company has created a platform that enables measurable safety verification, utilizing a coverage-driven methodology that has been successfully applied in the semiconductor industry. This platform facilitates the analysis of safety-related metrics to ensure comprehensive coverage of various driving scenarios, allowing clients to confirm that their vehicles perform safely in critical situations. By addressing the challenges of verifying increasingly complex automated driving systems, Foretellix aims to reduce risks, costs, and time to market for autonomous vehicle deployment.